Living Medicine Articles & Analysis
20 news found
Given the strong commitment from Belgium and the European Union towards supporting regional production autonomy in the region, and the fact that the mRNA Technology Transfer Program co-led by the World Health Organization (WHO) and Medicines Patent Pool (MPP), is at the epicenter of this global effort, the Royal delegation made it a point to include a visit to Afrigen as part of ...
ByeTheRNA
(AskBio), a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to developing life-saving medicines and changing lives. The company maintains a portfolio of clinical programs across a range of neuromuscular, central nervous system, cardiovascular and metabolic disease indications with a ...
ByBayer AG
(“Virica”), a leading developer of solutions for scaling of viral medicines, will be featured in a live webinar to be held on Monday, November 14, 2022, at 2:30pm EST. ...
This most recent FDA approval incorporates VIDA’s deep-learning algorithms, which improve the automated segmentation of the lung and lobes for greater clinical and diagnostic precision, applying the highest standards of technology to clinical practice. “We’re living in the age of personalized medicine, where precision algorithms can be used to ...
Results from the trial were presented at ESC Congress 2021, and simultaneously published in the New England Journal of Medicine. Patients living with chronic kidney disease associated with type 2 diabetes are three times more likely to die from a cardiovascular event than those with type 2 diabetes alone. ...
ByBayer AG
Onegene Biotechnology is pioneering multi-target therapeutics to create breakthrough medicines that will transform the lives of people with complex and chronic diseases. ...
Ovid Therapeutics (NASDAQ:OVID) (“Ovid”), a biopharmaceutical company committed to developing medicines that transform the lives of people with neurological diseases, and Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery, today announced that Healx has secured from Ovid an exclusive option to ...
This peer-reviewed article describes the design of the trial which investigated Lomecel-B, a living cell therapy product, as a regenerative medicine strategy for the treatment of frailty in older adults. ...
“We build on our successful collaboration and by combining Dicerna’s state-of-the-art RNAi drug engine and intracellular delivery with our deep capabilities in disease biology understanding and tissue targeting through peptides and proteins we have the potential to expand our pipeline and deliver life-changing precision medicines for people living ...
BlueRock Therapeutics, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer?AG, announced?today?that Emile Nuwaysir, Ph.D., current President and CEO, will transition to the position of BlueRock Board Chair, effective August 1, 2021. Current Chief Scientific Officer Seth Ettenberg, Ph.D., will assume the role of President and CEO. BlueRock will continue in its mission ...
"We are very excited to launch this new strategic partnership with Citrine Medicine,"said Yong Liu, President of Sinopharm Group. "As a leading biopharmaceutical company in China, Citrine Medicine is working to introduce multiple innovative drugs to serve patients with rare diseases. ...
INOVIO's management will host a live conference call and webcast at 4:30 p.m. Eastern Standard Time today to discuss financial results and provide a general business update, including: top-line efficacy data from REVEAL 1, a Phase 3 clinical trial of VGX-3100; a progress update for the company's INNOVATE Phase 2/3 COVID-19 vaccine clinical trial and its development strategy ...
This unprecedented achievement opens the door to new options for patients who live in remote areas and require swift treatment to successfully treat cardiovascular diseases. ...
ByRobocath
” “I’m excited to work with Brendan and the team to deliver on the promise of our platform and bring new medicines to patients,” said Kay. “I’ve been wondering about what AI means for drug development for some time; there’s a lot of talk out there that sounds like magic. ...
Redbiotec AG has entered into a research collaboration and exclusive option agreement with a large-cap pharmaceutical company. The collaboration will leverage Redbiotec’s proprietary bacteria platform BRISPR® for the targeted delivery of gene therapy cargos from the partner. “Redbiotec’s bacteria hold great potential in overcoming the delivery hurdles faced by conventional ...
Redbiotec AG, a pioneer in living medicines, further expands its Scientific Advisory Board with the appointment of Professor Michele Calos, PhD. ...
Redbiotec AG, a pioneer in living medicines, is pleased to announce the addition of Professor Christoph U. ...
Both the U.S. and China are committed to policies and investment that accelerate the adoption of precision medicine globally. In China, precision medicine is a prominent part of the 13th Five-Year Plan, which sets an ambitious roadmap and budget. The Summit, "Transforming Lives through Pioneering Precision Medicine," featured ...
“Based on our ongoing studies, tissue-integrated sensor technology has the potential to enable wearables to live up to the promise of personalized medicine, revolutionizing the management of health in wellness and ...
The development of child-resistant packaging on medicines and household chemicals and the banning of lead-based paint have had a significant impact in preventing poisonings and making homes safer. ...